Global Peptide Market Projected to Reach $50 Billion by 2030

Industry analysts report that the global peptide therapeutics market is expected to exceed $50 billion by 2030, driven by increasing demand for GLP-1 weight loss therapies and metabolic health research. Peptides such as Semaglutide and Tirzepatide continue to gain significant traction among research institutions and pharmaceutical developers.

Dejia Company closely monitors these market trends and remains committed to supplying high-purity research peptides to support preclinical studies and formulation development. The company ensures all products meet international research standards through rigorous third-party testing.

As the peptide industry evolves, Dejia Company aims to stay at the forefront of quality, service, and innovation.